Skip to main content
. 2021 May 28;8(4):e1005. doi: 10.1212/NXI.0000000000001005

Figure 2. Probability of Clinically Definite Multiple Sclerosis Over 4 Years.

Figure 2

The probability of development of a second clinical attack, i.e., conversion to CDMS, during the 4-year follow-up period was higher in the high κ-FLC index (>100) group (n = 19) than in the low κ-FLC index (≤100) group (n = 69; p = 0.009). κ-FLC = κ-free light chain; CDMS = clinically definite multiple sclerosis.